Table 4.
Groups | Cont | HFD | HFD+ EEA (200mg/kg / bw) |
HFD+EEA (400mg/kg/bw) | HFD+ATOR |
---|---|---|---|---|---|
TG (mmol/L) | 1.00 ± 0.29 | 2.50±0.40∗∗∗ | 1.13 ± 0.20### | 0.8± 0.42### | 1.00 ± 0.29### |
T-Ch (mmol/L) | 1.37 ± 0.12 | 3.50±0.55∗∗∗ | 1.60 ± 0.15### | 1.70 ± 0.15### | 1.62 ± 0.08### |
LDL- c (mmol/L) | 0.60 ± 0.19 | 1.80±0.07∗∗∗ | 1.30± 0.35### | 0.80 ± 0.01### | 0.45 ± 0.40### |
HDL-c (mmol/L) | 1.44 ± 0.33 | 0.50±0.10∗∗∗ | 0.80 ± 0.33### | 1.19± 0.07###¥ | 0.76 ± 0.08### |
AIP | 0.95 ± 0.17 | 6.88±0.14∗∗∗ | 2.00 ± 0.12### | 1.48 ±0.19###¥¥ | 2.13 ± 0.20### |
CRI-I | 0.951 | 7 | 2 | 1.42 | 2.13 |
HFD groups were orally administered with ethanol extract (EEA) from leaves of C. scolymus and atorvastatin (ATOR) at the doses mentioned earlier for 60 days. Values are given as means ± SD (n = 6). ∗∗∗ p ≤ 0.001 was considered significant compared to control groups; ### p ≤ 0.001 was considered significant compared to HFD groups; ¥p ≤ 0.05 and ¥¥ p ≤ 0.01 were considered significant compared to HFD groups treated with ATOR.